[go: up one dir, main page]

CL2008000928A1 - Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. - Google Patents

Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida.

Info

Publication number
CL2008000928A1
CL2008000928A1 CL2008000928A CL2008000928A CL2008000928A1 CL 2008000928 A1 CL2008000928 A1 CL 2008000928A1 CL 2008000928 A CL2008000928 A CL 2008000928A CL 2008000928 A CL2008000928 A CL 2008000928A CL 2008000928 A1 CL2008000928 A1 CL 2008000928A1
Authority
CL
Chile
Prior art keywords
infant
risk
manufacture
life
cgmcc
Prior art date
Application number
CL2008000928A
Other languages
English (en)
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38330170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000928(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2008000928A1 publication Critical patent/CL2008000928A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE AL USO DE BACTERIA PREBIÓTICA CAPAZ DE FAVORECER EL DESARROLLO DE UNA MICROBIOTA INTESTINAL BIFIDOGÉNICA TEMPRANA EN LA FABRICACIÓN DE UN MEDICAMENTO O DE UNA COMPOSICIÓN NUTRICIONAL TERAPÉUTICA ADECUADA PARA<br /> REDUCIRLE RIESGO DEL DESARROLLO DE UNA CONDICIÓN DE SOBREPESO O DE LA OBESIDAD EN LA VIDA POSTERIOR DE UN INFANTE.<br />  
CL2008000928A 2007-03-28 2008-03-28 Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. CL2008000928A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07105072A EP1974734A1 (en) 2007-03-28 2007-03-28 Probiotics for reduction of risk of obesity

Publications (1)

Publication Number Publication Date
CL2008000928A1 true CL2008000928A1 (es) 2009-08-07

Family

ID=38330170

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008000928A CL2008000928A1 (es) 2007-03-28 2008-03-28 Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida.

Country Status (16)

Country Link
US (1) US20100111915A1 (es)
EP (2) EP1974734A1 (es)
CN (1) CN101646445B (es)
AU (1) AU2008231922B2 (es)
BR (1) BRPI0809624A2 (es)
CA (1) CA2677636A1 (es)
CL (1) CL2008000928A1 (es)
ES (1) ES2462747T5 (es)
MX (1) MX2009008782A (es)
MY (1) MY158816A (es)
PL (1) PL2129386T3 (es)
PT (1) PT2129386E (es)
RU (1) RU2464994C2 (es)
TW (1) TW200906427A (es)
UA (1) UA96795C2 (es)
WO (1) WO2008116700A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370729B (zh) * 2005-07-26 2012-08-29 三菱电机株式会社 乘客输送机
EP2011506A1 (en) 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
AU2009228716B2 (en) * 2008-03-28 2015-01-15 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
EP2459202A1 (en) * 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
WO2011034166A1 (ja) * 2009-09-17 2011-03-24 森永乳業株式会社 抗肥満剤、抗肥満用飲食品、耐糖能改善剤及び耐糖能改善用飲食品
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
FR2955774A1 (fr) * 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
NL2004200C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
EP2452572A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
ES2389547B1 (es) 2010-12-07 2013-08-08 Consejo Superior De Investigaciones Científicas (Csic) Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
EP2514435A1 (en) * 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
ES3005933T3 (en) 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
CA2841567A1 (en) * 2011-07-22 2013-01-31 Nestec S.A. Methods for reducing childhood obesity and for calculating childhood obesity risk
FI20116008A0 (fi) 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
FI126711B (fi) 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
KR20210013352A (ko) * 2012-09-20 2021-02-03 프로테라 인코포레이티드 비만 및 비만 관련 질환을 치료하기 위한 프로바이오틱 조성물 및 방법
CN108271917A (zh) 2013-03-08 2018-07-13 艾斯姆食品公司 大米蛋白补充剂
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
EP3091988B1 (en) 2014-01-10 2020-09-02 Société des Produits Nestlé S.A. Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring of overweight and/or obese mothers
US9980950B2 (en) 2014-01-10 2018-05-29 Nestec S.A. Maternal vitamin B6 administration for the prevention of increased adiposity, overweight or obesity in the offspring
MX2017001734A (es) * 2014-08-08 2017-04-27 Nestec Sa Mioinositol y probioticos y usos.
CN116270762A (zh) * 2014-08-08 2023-06-23 雀巢产品有限公司 肌肌醇和一种或多种益生菌以及它们的用途
MX374378B (es) * 2014-08-08 2025-03-06 Soc Des Produits Nestle S A Star Mioinositol y probioticos, y uso de estos.
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
USD796775S1 (en) 2015-09-09 2017-09-12 Intercontinental Great Brands Llc Confection
RU2740096C2 (ru) * 2015-12-11 2021-01-11 Элиментари Хелт Лимитед Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
BR112019028039A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia
EP3645024B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing fatty liver disease
AU2018414925B2 (en) * 2018-03-23 2023-05-04 Morinaga Milk Industry Co., Ltd. Composition for promoting the secretion of FGF21
WO2019180965A1 (ja) 2018-03-23 2019-09-26 森永乳業株式会社 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
KR102156399B1 (ko) * 2018-04-11 2020-09-16 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
CA3108735A1 (en) 2018-09-06 2020-03-12 Frieslandcampina Nederland B.V. Bifidogenic hypoallergenic gos compositions and methods for providing the same involving beta-galactosidase from a strain of lactobacillus delbrueckii ssp bulgaricus
CN109593678B (zh) * 2018-12-25 2020-11-10 嘉兴益诺康生物科技有限公司 长双歧杆菌yh295及其在制备降低腹型肥胖风险产品中的应用
CN111374256A (zh) * 2018-12-29 2020-07-07 内蒙古蒙牛乳业（集团）股份有限公司 益生菌组合物及其用途、食品和药品
CN114745969A (zh) * 2019-12-05 2022-07-12 N·V·努特里奇亚 用于改善超重和肥胖母亲所生的婴儿出生后生长的具有特殊脂质结构的婴儿配方物
EP4081225A1 (en) 2019-12-27 2022-11-02 Biopolis, S.L. Uses of lipoteichoic acid from bifidobacteria

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) † 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
FI110668B (fi) † 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
JP4108613B2 (ja) * 2002-04-12 2008-06-25 チェビジェン・インコーポレイテッド 共役リノール酸を生産する新規の菌主、これを含有するカプセル剤及びその製造方法
CN1457654A (zh) * 2003-06-04 2003-11-26 周霞轩 蒲公英儿童植物奶及制配与工艺
EP1638415B1 (en) † 2003-06-23 2010-12-15 Nestec S.A. Infant or follow-on formula
ES2326481T3 (es) * 2003-06-23 2009-10-13 Nestec S.A. Formula para recien nacidos o formula de continuacion.
US7001756B1 (en) † 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
CN100396770C (zh) † 2004-03-19 2008-06-25 景岳生物科技股份有限公司 新的微生物鼠李糖乳杆菌gm-020及其治疗肥胖的用途
KR100686557B1 (ko) † 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
DE602004015169D1 (de) * 2004-11-26 2008-08-28 Nutricia Nv Kleinkindernahrung mit proteasehemmer
WO2006091103A2 (en) * 2005-02-28 2006-08-31 N.V. Nutricia Nutritional composition with probiotics
EP1926395A1 (en) † 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
US7303745B2 (en) † 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233752A1 (en) † 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture

Also Published As

Publication number Publication date
RU2464994C2 (ru) 2012-10-27
CA2677636A1 (en) 2008-10-02
AU2008231922B2 (en) 2013-08-01
PT2129386E (pt) 2014-04-29
CN101646445A (zh) 2010-02-10
UA96795C2 (ru) 2011-12-12
ES2462747T5 (es) 2022-09-27
ES2462747T3 (es) 2014-05-26
MX2009008782A (es) 2009-08-24
RU2009139665A (ru) 2011-05-10
BRPI0809624A2 (pt) 2014-09-23
EP2129386B1 (en) 2014-04-16
US20100111915A1 (en) 2010-05-06
MY158816A (en) 2016-11-15
EP2129386B2 (en) 2022-05-18
WO2008116700A1 (en) 2008-10-02
EP1974734A1 (en) 2008-10-01
CN101646445B (zh) 2014-01-08
AU2008231922A1 (en) 2008-10-02
PL2129386T3 (pl) 2014-09-30
TW200906427A (en) 2009-02-16
EP2129386A1 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
CL2008000928A1 (es) Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida.
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
CL2011000891A1 (es) Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
CL2008000927A1 (es) Uso de bataerias probioticas lactobacillus rhamnosus y bifidobacterium longum para la preparacion de un medicamento o composicion terapeutica nutricional, tal como una formula infantil, destinada a la administracion a un infante para la profilaxis a largo plazo de la diarrea.
CL2008001993A1 (es) Uso de bacterias probioticas lactobacillus y bifidobacterium en la preparacion de una composicion para normalizar la concentracion de glucosa plasmatica, aumentar la respuesta a insulina y prevenir la diabetes gestacional.
AR072435A1 (es) Composicion nutricional para lactantes nacidos por cesarea
RU2010142003A (ru) Синбиотическая смесь
BR112013016914A2 (pt) combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
JP2009539371A5 (es)
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
AR071968A1 (es) Uso de un oligosacarido en el tratamiento de la inflamacion intestinal
BR112014009418A2 (pt) macrociclos peptidomiméticos
AR078485A1 (es) Bifidobacterium longum atcc baa-999 (bl999) y control de peso
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
BRPI0818079A8 (pt) Composição de lipídeo
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
PA8846101A1 (es) Anticuerpos del receptor ii anti-tgf-beta
ES2571998T3 (es) Composiciones y usos médicos de derivados del ajoeno
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
EP4410298A3 (en) Therapeutic microvesicles of probiotic bacteria
UY32650A (es) Medicamento para la administración oral que contiene al menos un esterógeno y/o al menos un gestágeno y al menos una cepa de bacterias probióticas
CO6531433A2 (es) Administración enteral del dipéptido arginina-glutamina para repaldar el desarollo retiniano, intestinal, o del sistema nervioso
BR112015010639A2 (pt) lactobacillus rhamnosus para redução da acumulação de gordura corporal
AR063809A1 (es) Nuevas cepas de bifidobacterias sensibles a la tetraciclina